Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects

NCT01713803 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped FDA did not require a clinical trial for indication.

Conditions

Opioid Dependence

Interventions

DRUG: Buprenorphine and naloxone

Sponsor

BioDelivery Sciences International